Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?
Maciá Bobes, C.; Ronzón Fernández, Aánzazu.; Fernández García, E.
Atencion Primaria 39(3): 163-164
2007
ISSN/ISBN: 0212-6567 PMID: 17386212 Document Number: 605489
Document emailed within 1 workday
Related Documents
Guo, Y.F. 2019: Effects of aspirin on primary prevention of cardiovascular events in patients with hypertension Zhonghua Nei Ke Za Zhi 58(4): 249-251Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Burrill, P.D. 2010: Aspirin in primary prevention. Evidence is lacking Bmj 340: C1613
Beermann, Börn. 2006: Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty Lakartidningen 103(47): 3731-3732
De Caterina, R. 2003: Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(4): 228-231
Iavelov, I.S. 2006: Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials) Kardiologiia 46(3): 75-76
De Caterina, R. 2001: The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(6): 681-684
Young, F.E.; Nightingale, S.L.; Temple, R.A. 1988: The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction JAMA 259(21): 3158-3160
Sawanyawisuth, K.; Limpawattana, P.; Bumrerraj, S.; Thongmee, A.; Kosakarn, J.; Choenrungroj, T.; Pradit, P.; Naranunn, P.; Punyamee, S.; Premgamone, A. 2005: Aspirin therapy as primary prevention in hypertensive patients at Srinagarind hospital Journal of the Medical Association of Thailand 88(12): 1797-1801
Chazov, E.I. 2002: Problems in primary and secondary prevention of cardiovascular diseases Terapevticheskii Arkhiv 74(9): 5-8
Schlierf, G. 1980: Primary and secondary prevention of cardiovascular diseases - metabolic aspects Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 546-550
Tkacheva, O.N.; Sharashkina, N.V. 2010: Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases Kardiologiia 50(8): 63-66
Yokota, C. 2003: Prevention of cardiovascular disease in type 2 diabetic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1161-1166
Hiatt, W.R. 2008: Aspirin for prevention of cardiovascular events Bmj 337: A1806
Zhdan, V.M.; Holovanova, I.A.; Filatova, V.L.; Khorosh, M.V. 2017: Medical evaluation of efficiency of optimized models for early detection and primary prevention of cardiovascular diseases Wiadomosci Lekarskie 70(3 Pt 1): 433-438
Kulbertus, H. 2005: Aspirin and cardiovascular prevention: last minute information Revue Medicale de Liege 60(3): 198-200
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Pavić, J.; Zupanić, M.; Milanović, S.Musić.; Fister, K. 2009: Primary and secondary prevention of cardiovascular diseases embedded in the visiting nurse services: description of the intervention model Collegium Antropologicum 33 Suppl. 1: 81-86
Grundy, S., M.; Balady, G., J.; Criqui, M., H.; Fletcher, G.; Greenland, P.; Hiratzka, L., F.; Houston-Miller, N.; Kris-Etherton, P.; Krumholz, H., M.; Larosa, J.; Ockene, I., S.; Pearson, T., A.; Reed, J.; Washington, R.; Smith, S., C.,. Jr.; 1997: Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the Task Force on Risk Reduction Circulation 95(9): 2329-2331